ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Biotechnology

Healthcare
$12.82 +0.73%

+$0.13 today

Market cap
$1.42B
Beta
0.00
52W Low $16.64High $23.21

Volume 0.65M

Average 1.06M

ADRX Other Non-current Assets

Long-term assets not reported separately.

No reported Other Non-current Assets figures are available to summarize.

Other Non-current Assets history

Currency unavailable · from the balance sheet

No Other Non-current Assets data reported for this period type.

Other Non-current Assets vs competitors

How ADRX compares with its peers on the latest reported figures

ADRX Competitors
Other Non-current Assets for ADRX and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
PRMEPrime Medicine, Inc.Mar 2026$14.69M USD+4.5%-1.0%5.0%
MGTXMeiraGTx Holdings plcMar 2026$3.68M USD+18.1%+34.5%1.5%
STOKStoke Therapeutics, Inc.Mar 2026$3.23M USD+347.6%+472.0%0.7%
ARCTArcturus Therapeutics Holdings Inc.Mar 2026$2.03M USD-89.0%—0.8%
WVEWave Life Sciences Ltd.Mar 2026$386K USD-90.9%-83.7%0.1%
SLNSilence Therapeutics plcMar 2026$127K USD-96.5%—0.1%
BNTCBenitec Biopharma Inc.Mar 2026$67K USD-25.6%-19.6%0.0%
PRQRProQR Therapeutics N.V.Mar 2026€0 EUR——0.0%
RNAAtrium Therapeutics, Inc.Mar 2026$0 USD——0.0%
ADRXADARx Pharmaceuticals, Inc.—— ———
Peer median (excluding ADRX) —-25.6%-1.0%0.1%

Competitors are the stored peer set for ADRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Intrinsic Alpha fair value

Locked

Current Price

$12.82

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.